Dear Colleagues,

This Special Issue invites scholarly contributions centered on advancements and innovations in the realm of COVID-19 vaccines and vaccination strategies. Considering the ongoing evolution and global impact of COVID-19, the importance of continuous scientific exploration cannot be overstated.

This issue invites contributions addressing a broad array of topics encompassing emerging vaccine technologies, safety and efficacy evaluations of current and new vaccines, the influence of viral variants on vaccine potency, and the role of immunological responses stimulated by vaccines.

We encourage submissions from a diverse array of academic disciplines, including but not limited to virology, immunology, biologics—including vaccines, targeted specific antibodies, and the exploration of recombinant therapeutic proteins—and nanobiotechnology-driven products for the treatment and prevention of COVID-19. The objective is to inspire a multi-disciplinary approach that enhances our knowledge and aids in the fight against the enduring pandemic. The ultimate aspiration of this Special Issue is to serve as a holistic academic resource to stimulate novel insights for future research, facilitate strategic policy planning, and refine clinical practice.

Dr. Abu Baker Sheikh
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• COVID-19 vaccines
• global health
• emerging vaccine technologies
• vaccine efficacy
• immunological responses
• vaccine acceptance
• health disparities